About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Congenital Broncho-esophageal Fistula in an Adult

how much does it cost to get an abortion

pregnancy abortion adventureswithtravisandpresley.com
Vishnu Sharma M1, Dr Harsha DS2, Alka C Bhat3, Ganesh K4, Madhav Kamath5
Department of 1Respiratory Medicine, 2Radiodiagnosis, 3Cardiothoracic Surgery; A J Institute of Medical Sciences, Mangalore, Karnataka, India.
Corresponding Author:
Dr. Vishnu Sharma M
Email: drvishnusharmag@gmail.com
Received: 01-JUL-2016 Accepted: 19-SEP-2016 Published Online: 05-NOV-2016
DOI: http://dx.doi.org/10.17659/01.2016.0126
Abstract
Congenital broncho-esophageal fistula in adults is a rare presentation. This birth defect arises in early fetal life leading to presentation of symptoms immediately after birth. Less than 300 cases in adults have been reported in world literature. We report a case in a 31 year old female who presented with symptoms of aspiration since three months. On evaluation she was found to have congenital broncho-esophageal fistula. She was treated with fistulectomy and made uneventful recovery. 
Keywords : Barium, Bronchial Fistula, Digestive System, Esophageal Atresia, Esophageal Fistula.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Dec 04, 2024